Company profile for DCprime

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

What drives us is the realization that there is still a lot to be won in the treatment of cancer. Not only in terms of survival, but also in the quality of life of people living with cancer. DCprime aims to make a meaningful contribution to the field of immuno-oncology, by bringing highly relevant and safe cancer vaccines to market. This requires a deeper understanding of underlying disease mechanisms, including interaction be...
What drives us is the realization that there is still a lot to be won in the treatment of cancer. Not only in terms of survival, but also in the quality of life of people living with cancer. DCprime aims to make a meaningful contribution to the field of immuno-oncology, by bringing highly relevant and safe cancer vaccines to market. This requires a deeper understanding of underlying disease mechanisms, including interaction between tumour and immune system, in which we continue to invest. We anticipate that disruptive new cancer treatments will be the result of collaborative efforts, so we strive to work together with relevant academic groups

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Netherlands
Address
Address
Galileïweg 8 2333 BD Leiden
Telephone
Telephone
+31 71 3322627
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://dcprime.com/dcprime-presents-preclinical-data-at-sitc-2020-validating-the-use-of-its-cell-based-cancer-relapse-vaccine-in-ovarian-cancer/

DCPRIME
09 Nov 2020

https://dcprime.com/dcprime-to-present-interim-clinical-data-of-advance-ii-trial-in-oral-presentation-at-ash2020/

PRESS RELEASE
05 Nov 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty